Intracavitary chemotherapy.
D000880:Anthraquinones / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D016190:Carboplatin; D002408:Catheters, Indwelling; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy; D007263:Infusions, Parenteral / Q000379:methods*; D008558:Melphalan / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008937:Mitomycins / Q000008:administration & dosage; D008942:Mitoxantrone; D009369:Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage
D000880:Anthraquinones; D000970:Antineoplastic Agents; D008937:Mitomycins; D009944:Organoplatinum Compounds; D003561:Cytarabine; D001761:Bleomycin; D005047:Etoposide; D004317:Doxorubicin; D016190:Carboplatin; D008942:Mitoxantrone; D002945:Cisplatin; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate